Literature DB >> 17056623

Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome.

P A Ringleb1, Ch Schwark, M Köhrmann, S Külkens, E Jüttler, W Hacke, P D Schellinger.   

Abstract

BACKGROUND: Owing to the fear of an increased bleeding risk, thrombolytic therapy is withheld from many patients with acute stroke > 80 years of age.
OBJECTIVE: To analyse the risk for symptomatic intracranial haemorrhage (sICH), morbidity and mortality after thrombolytic therapy in octogenarians focusing, in particular, on whether patients selected using magnetic resonance imaging (MRI) had a better risk:benefit ratio.
METHODS: The prospectively collected single-centre data of all patients treated with systemic thrombolytic therapy for acute ischaemic stroke since 1998 (n = 468) were reviewed, and patients > or = 80 years (n = 90) were compared with those aged < 80 years (n = 378). In addition, the group of octogenarians was analysed with respect to initial imaging modality.
RESULTS: The overall rate of sICH in the octogenarians was 6.9%, compared with 5.3% in younger patients (p = 0.61). In older patients selected by computed tomography, the rate of sICH was 9.4%; no patient selected by MRI had sICH (p = 0.10). Mortality in the octogenarians selected by computed tomography was 29.7% after 3 months as compared with 26.9% in the patients selected by MRI (p = 1.0). 20.3% of the octogenarians selected by computed tomography and 15.4% of those selected by MRI had a favourable outcome (modified Rankin scale < or = 1) after 3 months (p = 0.77).
CONCLUSION: Compared with younger patients, octogenarians do not have an increased risk of sICH. The use of MRI to select octogenarians for thrombolytic therapy seemed to decrease the risk of sICH, but did not influence the overall outcome after 3 months.

Entities:  

Mesh:

Year:  2006        PMID: 17056623      PMCID: PMC2117694          DOI: 10.1136/jnnp.2006.105890

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

Review 1.  Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.

Authors:  N Hjort; K Butcher; S M Davis; C S Kidwell; W J Koroshetz; J Röther; P D Schellinger; S Warach; L Østergaard
Journal:  Stroke       Date:  2004-12-23       Impact factor: 7.914

2.  Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

Authors: 
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

3.  Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.

Authors:  Michael D Hill; Alastair M Buchan
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

4.  Intravenous TPA for very old stroke patients.

Authors:  Chin-I Chen; Yasuyuki Iguchi; James C Grotta; Zsolt Garami; Ken Uchino; Hashem Shaltoni; Andrei V Alexandrov
Journal:  Eur Neurol       Date:  2005-10-18       Impact factor: 1.710

5.  Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.

Authors:  David M Kent; Lori Lyn Price; Peter Ringleb; Michael D Hill; Harry P Selker
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

6.  Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis.

Authors:  S T Engelter; M Reichhart; L Sekoranja; D Georgiadis; A Baumann; B Weder; F Müller; R Lüthy; M Arnold; P Michel; H P Mattle; B Tettenborn; H J Hungerbühler; R W Baumgartner; R Sztajzel; J Bogousslavsky; P A Lyrer
Journal:  Neurology       Date:  2005-10-12       Impact factor: 9.910

7.  Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.

Authors:  Marc Ribo; Carlos A Molina; Alex Rovira; Manuel Quintana; Pilar Delgado; Joan Montaner; Elisenda Grivé; Juan F Arenillas; José Alvarez-Sabín
Journal:  Stroke       Date:  2005-02-03       Impact factor: 7.914

8.  Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients.

Authors:  M S Mouradian; A Senthilselvan; G Jickling; J A McCombe; D J Emery; N Dean; A Shuaib
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

9.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

10.  Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre.

Authors:  R J van Oostenbrugge; R M M Hupperts; J Lodder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

View more
  18 in total

1.  Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥ 80 years of age.

Authors:  Gregoire Boulouis; Frederic Dumont; Charlotte Cordonnier; Marie Bodenant; Didier Leys; Hilde Hénon
Journal:  J Neurol       Date:  2011-12-20       Impact factor: 4.849

2.  Thrombolysis therapy in octogenarians.

Authors:  Valeria Caso; Maurizio Paciaroni; Giancarlo Agnelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-21       Impact factor: 10.154

3.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack : part 2].

Authors:  P D Schellinger; P Ringleb; W Hacke
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

Review 4.  Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients.

Authors:  Laurent Derex; Norbert Nighoghossian
Journal:  Nat Rev Neurol       Date:  2009-08-04       Impact factor: 42.937

Review 5.  [Difficult decisions in stroke therapy].

Authors:  M Endres; M Grond; W Hacke; M Ebinger; P D Schellinger; M Dichgans
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

6.  Interventional stroke therapies in the elderly: are we helping?

Authors:  N Zeevi; G A Kuchel; N S Lee; I Staff; L D McCullough
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-24       Impact factor: 3.825

7.  [Thrombolytic treatment of acute stroke].

Authors:  H Amiri; W Hacke; J Bösel
Journal:  Internist (Berl)       Date:  2011-11       Impact factor: 0.743

Review 8.  Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurohospitalist       Date:  2015-07

9.  Impact of leukoaraiosis on parenchymal hemorrhage in elderly patients treated with thrombolysis.

Authors:  Norbert Nighoghossian; Fatima Abbas; Tae-Hee Cho; Ana Filipa Geraldo; Vincent Cottaz; Elie Janecek; Laura Mechtouff; Magali Bischoff; Carlos El Khoury; Anne Marie Schott; Laurent Derex; Marc Hermier; Louis Guy Tisserand; Roxana Amelie; Leila Chamard; Yves Berthezene
Journal:  Neuroradiology       Date:  2016-07-22       Impact factor: 2.804

Review 10.  Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.

Authors:  Hakan Sarikaya
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.